Summary
Used cloud-scale AI to model proteins as dynamic conformational ensembles rather than static structures. Enabled large-scale molecular simulation and generative small-molecule design against complex targets. Accelerated screening and reduced experimental bottlenecks through elastic high-performance computing. Improved early risk detection and supported more precise, human-relevant drug development.